ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CDXS Codexis Inc

2.76
0.00 (0.00%)
Pre Market
Last Updated: 04:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 2.70
Ask Price 3.71
News -
Day High

Low
1.45

52 Week Range

High
4.91

Day Low
Company Name Stock Ticker Symbol Market Type
Codexis Inc CDXS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 2.76 04:00:00
Open Price Low Price High Price Close Price Prev Close
2.76
Trades Volume Avg Volume 52 Week Range
0 0 - 1.45 - 4.91
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.76 USD

Codexis Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
194.04M 70.30M - 70.14M -76.24M -1.08 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Codexis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CDXS Message Board. Create One! See More Posts on CDXS Message Board See More Message Board Posts

Historical CDXS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.123.192.612.83391,565-0.36-11.54%
1 Month3.493.71872.613.22360,377-0.73-20.92%
3 Months2.744.912.533.46590,4360.020.73%
6 Months1.974.911.512.83688,2380.7940.10%
1 Year4.364.911.452.65844,321-1.60-36.70%
3 Years23.3142.011.4510.45773,374-20.55-88.16%
5 Years19.5042.011.4512.16627,242-16.74-85.85%

Codexis Description

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment.

Your Recent History

Delayed Upgrade Clock